[{"address1": "4868 Rue Levy", "address2": "Suite 220", "city": "Montreal", "state": "QC", "zip": "H4R 2P1", "country": "Canada", "phone": "514 332 4888", "website": "https://www.engene.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Gu\u00e9rin (BCG). enGene Holdings Inc. is based in Montreal, Canada.", "fullTimeEmployees": 56, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alex  Nichols Ph.D.", "age": 39, "title": "Chief Strategy & Operations Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 504442, "exercisedValue": 0, "unexercisedValue": 3900970}, {"maxAge": 1, "name": "Mr. Ronald H. W. Cooper", "age": 61, "title": "Chief Executive Officer & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony T. Cheung Ph.D.", "age": 52, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 341754, "exercisedValue": 0, "unexercisedValue": 13448566}, {"maxAge": 1, "name": "Mr. John C. Brown D.Sc., FRSC, Ph.D.", "title": "Co-Founder and Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Ryan Daws", "age": 50, "title": "CFO & Head of Business Development", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Joan  Connolly", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee G. Giguere", "age": 43, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tara  Place M.B.A.", "title": "Senior VP of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sharon  Tan", "title": "VP of Project Management & Head of Program Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raj  Pruthi F.A.C.S., M.D., M.H.A.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.25, "open": 6.11, "dayLow": 5.507, "dayHigh": 6.59, "regularMarketPreviousClose": 6.25, "regularMarketOpen": 6.11, "regularMarketDayLow": 5.507, "regularMarketDayHigh": 6.59, "beta": -0.647, "forwardPE": -2.891661, "volume": 112760, "regularMarketVolume": 112760, "averageVolume": 158230, "averageVolume10days": 77500, "averageDailyVolume10Day": 77500, "bid": 5.61, "ask": 6.07, "bidSize": 100, "askSize": 100, "marketCap": 300762528, "fiftyTwoWeekLow": 4.42, "fiftyTwoWeekHigh": 18.4, "fiftyDayAverage": 7.0476, "twoHundredDayAverage": 8.358525, "currency": "USD", "enterpriseValue": 87452392, "floatShares": 29046000, "sharesOutstanding": 50976700, "sharesShort": 28939, "sharesShortPriorMonth": 75702, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.00059999997, "heldPercentInsiders": 0.13606, "heldPercentInstitutions": 0.93171, "shortRatio": 0.16, "shortPercentOfFloat": 0.0008, "impliedSharesOutstanding": 54000700, "bookValue": 5.348, "priceToBook": 1.1032162, "lastFiscalYearEnd": 1730332800, "nextFiscalYearEnd": 1761868800, "mostRecentQuarter": 1730332800, "netIncomeToCommon": -55142000, "trailingEps": -1.46, "forwardEps": -1.69, "enterpriseToEbitda": -1.406, "52WeekChange": -0.5885451, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ENGN", "underlyingSymbol": "ENGN", "shortName": "enGene Holdings Inc.", "longName": "enGene Holdings Inc.", "firstTradeDateEpochUtc": 1643725800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f9f4e2ed-4011-3f93-916a-f8a188a8b358", "messageBoardId": "finmb_9516520", "gmtOffSetMilliseconds": -18000000, "currentPrice": 5.9, "targetHighPrice": 37.0, "targetLowPrice": 16.0, "targetMeanPrice": 27.0, "targetMedianPrice": 27.5, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 238332000, "totalCashPerShare": 4.675, "ebitda": -62206000, "totalDebt": 25022000, "quickRatio": 16.279, "currentRatio": 16.872, "debtToEquity": 9.179, "returnOnAssets": -0.19559, "returnOnEquity": -0.31957, "freeCashflow": -32461376, "operatingCashflow": -48281000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]